Clinical Trial

Anifrolumab Pregnancy Study

Name: Anifrolumab Pregnancy Study — clinical trial record (NCT07049653)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ROSE

Recruiting

View on ClinicalTrials.gov →

Summary

This is a non-interventional multi-database post-authorisation study to assess pregnancy-related safety data from women with SLE exposed to Anifrolumab.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2025-06-25; most recent amendment 2026-07-07.

Status change: Not Yet Recruiting → Recruiting 2026-06-23

Trial Details

NCT Number	NCT07049653
Lead Sponsor	AstraZeneca Collaborators: IQVIA Pty Ltd
Conditions	Systemic Lupus Erythematosus
Enrollment	500 participants
Start Date	2026-06-04
Primary Completion	2030-12-10 (estimated)
Study Completion	2030-12-10 (estimated)
Updated on ClinicalTrials.gov	2026-07-08